Global monkeypox outbreak 2022: First case series in Singapore.
10.47102/annals-acadmedsg.2022269
- Author:
Xuan Qi KOH
1
;
Martin Tze Wei CHIO
;
Mingjuan TAN
;
Yee Sin LEO
;
Roy Kum Wah CHAN
Author Information
1. Department of Dermatology, National Skin Centre, Singapore.
- Publication Type:Journal Article
- MeSH:
Disease Outbreaks;
Humans;
Monkeypox/epidemiology*;
Singapore/epidemiology*;
Travel-Related Illness
- From:Annals of the Academy of Medicine, Singapore
2022;51(8):462-472
- CountrySingapore
- Language:English
-
Abstract:
Monkeypox is a global health emergency. Prior to 2022, there were few reports of monkeypox outside of endemic countries, which were mostly travel-related. Since May 2022, an exponential increase in monkeypox infections in previously non-endemic countries has been reported. Unlike previous outbreaks of monkeypox, which were zoonotically transmitted and presented with generalised vesicular eruptions after prodromal symptoms, cases of the current outbreak feature significant travel and sexual history, and atypical localised genital eruptions with unpredictable onset relative to viral prodrome-like symptoms. We summarise the 15 Singapore cases reported to date as of August 2022, and highlight salient clinical clues that may aid physicians in narrowing the broad differential diagnosis of an acute vesicular genital eruption. Although research into vaccination and antiviral strategies is ongoing, monkeypox is currently conservatively managed. Clinical vigilance and a high index of suspicion are required to facilitate early detection and isolation of cases to contain transmission in Singapore.
